title: Effects of overshadowing on conditioned nausea in cancer patients: an experimental study.
abstract: The infusion of cytotoxic drugs in cancer patients is often accompanied by posttreatment nausea (PN). In addition, patients complain about nausea prior to an infusion [i.e., anticipatory nausea (AN)]. AN is mainly explained by classical conditioning, with the infusion as the unconditioned stimulus (US) and with the stimuli signaling the infusion as conditioned stimuli (CS). Despite this conditioning etiology, a specifically derived therapy to attenuate the CS-US contingency is missing. The purpose of this study is to develop and to test an overshadowing procedure for prevention of AN, and also for the modification of PN intensity. Sixteen cancer patients were assigned to one of two groups: Overshadowing+ (OV+) and Overshadowing- (OV-). At the start of all infusions of two consecutive chemotherapy cycles A and B (acquisition), OV+ subjects drank a saliently tasting beverage (the overshadowing CS), whereas group OV- drank water. All patients received water in cycle C (test). Self-reported symptoms and heart rates were recorded. As expected, in cycle C (test), no patient of group OV+ showed AN, whereas two patients of group OV- developed AN. There was a tendency for a reduction of the intensity of PN, in terms of duration and latency after overshadowing, in cycle C: OV+ patients tended to show a shorter duration and a longer latency between end of infusion and PN onset. In OV-, there was a significantly larger heart rate deceleration in both measurement periods, in the anticipatory and the posttreatment measurement period. Data suggest to apply overshadowing for prevention of AN and modification of PN. Physiological markers of conditioned nausea are revealed. After its procedural implementation, the technique can be used in larger samples now.
authors.affiliation: Institute of Medical Psychology, Heinrich-Heine-University Düsseldorf, Germany. ursula.stockhorst@uni-duesseldorf.de
authors.forename: U
authors.initials: U
authors.lastname: Stockhorst
authors.forename: J A
authors.initials: JA
authors.lastname: Wiener
authors.forename: S
authors.initials: S
authors.lastname: Klosterhalfen
authors.forename: W
authors.initials: W
authors.lastname: Klosterhalfen
authors.forename: C
authors.initials: C
authors.lastname: Aul
authors.forename: H J
authors.initials: HJ
authors.lastname: Steingrüber
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D003214:Conditioning, Classical / Q000187:drug effects / Q000502:physiology*; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced / Q000523:psychology*; D009369:Neoplasms / Q000150:complications / Q000523:psychology*; D013649:Taste / Q000187:drug effects
chemical_list: D000970:Antineoplastic Agents